PARTNERS

The ONCOCARE project involves a consortium between 5 partners:

Centre Hospitalier Universitaire de Liège

The CHU de Liège is the coordinator of the ONCOCARE project. It is a large academic hospital strongly experienced in the clinical care of cancer patients. It offers comprehensive diagnostic and therapeutic services to patients and their families. As referral center (over than 2,500 new cancers/year), CHU analyses more than 9,000 pathology specimens, perform more than 8,000 PET scanners, 31,000 chemotherapy preparation and 2,700 radiotherapy treatments every year. With almost 100 transplants/year, it is the second largest hematopoietic cell transplant center in Belgium and the most active internationally. It is the largest and most complete cancer center in the Wallonia Region. Furthermore, it is the only one, structurally connected with a University, mostly through the GIGA Research Institution. Finally, the CHU de Liège has recently created its integrated Cancer Institute to further strengthen its oncological activities. Its Integrated Oncology Center (CIO) dedicated to ambulatory care, is due to open in 2018. The Cancer Institute has set-up an ambitious strategic plan in which many essential items perfectly match the actions developed in OncoCare.

With its recognized expertise in transplantation (HCT), the CHU will be decisive for the JACIE accreditation. He conceptualized the HCT and PROM management tool, finalized the first phase of its clinical trial management tools, and launched a pilot phase of hospitalization at home.

Uniklinik RWTH Aachen

The Euregional Comprehensive Cancer Center Aachen (ECCA), founded in 2010, is focused on the improvement and the quality control in cancer patient care. Within the ECCA, structures and human resources have been organized to support programs in the field of personalized cancer medicine, access to new treatment options via clinical trials in an interdisciplinary, multi-professional, quality-controlled fashion. This includes SOPs regulating diagnostic patient work-up as well as patient-centered decision making,  interdisciplinary tumor boards, a clinical cancer registry and DIN-ISO as well as oncology specific (onkozert) certification of the core cancer center as well as its affiliate organ-specific cancer centers. The outreach program of the ECCA has established a cross-border network with oncology caregivers in local hospitals and private practices. This established basis for transborder collaboration mostly with the “Deutschsprachige Gemeinschaft” in east Belgium will now be extended further into the Euregio and novel important and highly innovative topics in cancer care will be developed jointly and made available to the patients in the Euregio.

With its major interest in myeloproliferative neoplasms, the ECCA will provide expertise in the cancer registry and clinical trials for rare cancers or with specific molecular alterations. Its medical software « 360 ° » will manage the care pathways. Certification of its QM system by the German Cancer Society will promote accreditation of similar programs among partners and synchronization with the NRW LKR registry.

Maastricht Universitair Medisch Centrum+

The Maastricht University Medical Center (MUMC+) is a pioneer in the field of European cross-border hospital cooperation. Its first exchange of patients and staff took place in the late eighties and has since been continuously intensified. Key elements of the medical cooperation strategy are “centre of excellence”, “complementarity” and “networks”.

Maastricht UMC+ is helping to meet the challenge of fighting cancer by forming the Maastricht Comprehensive Cancer Centre (Maastricht CCC), in which care and research are closely interwoven. The centre brings together existing institutes: the azM Oncology Centre, the GROW research school (School for Oncology and Developmental Biology), and the MAASTRO Clinic, a renowned radiology institute.

The work of the Maastricht CCC includes the development of preventative strategies for cancer through lifestyle changes, medicines and surgery. A great deal of emphasis is placed on increasing the accuracy of targeted treatment for individual patients on the basis of clinical and biomolecular characteristics.

With its solid program in hepato-pancreatico-biliary cancers (BPH), MUMC will share its expertise on improved post-surgical recovery through a pre-operative home-based program.

Jessa Ziekenhuis

The oncology centre of the Jessa Hospital is the largest centre for oncological care in the Belgian Limburg Province. Our focus is on the holistic care for our patients with cancer. In that view, we have the radiotherapy, hematology and medical oncology divisions incorporated in our department. The Limburg Oncology Center is strongly involved in delivering evidence-based cancer care to over 2,100 new cancer patients every year. The center also includes a clinical trial unit with a large experience in phase II, III and IV clinical trials. In addition, the Jessa hospital has obtained for several years the NIAZ accreditation, the hematology division received the JACIE accreditation for hematopoietic stem cell transplantation, and the medical oncology division the ESMO accreditation. Hence the Jessa hospital is strongly involved in quality management in general and in cancer care in particular.

JESSA will be an excellent example of a non-academic institution that will provide proof of concept for all the innovative tools developed by Oncocare.

 Bridge 2 Health

B2H is an entity devoted to life science project management for both the CHU and the University of Liège. B2H’s strength lies within the skills and qualification of its staff who, besides their well‐established scientific knowledge, has managed numerous research programs and networks both within the public and private sectors.

B2H has received the official empowerment from the CHU and the ULg to be responsible for the management of the OncoCare consortium.

As a consequence, B2H expertise in project management and coordination will ensure communication and follow-up of the project, deal with administrative matters (contracts, legal authorizations …) and financial, organize general or specific meetings and implement the dissemination of many deliverables to associated institutions.